Due to health issues, this site is no longer maintained and will be shut down shortly.

CHB Global X China Biotech Innovation ETF

Seeks to track, before fees and expenses, the Solactive China Biotech Innovation Index.The Index includes the top 30 companies based on market cap that are headquartered in Hong Kong or China and are listed in Hong Kong, China (via the Stock Connect program) or the U.S. and that are from the following industries according to the FactSet Industries and Economic Sectors: a) Biotechnology b) Pharmaceuticals: Other c) Pharmaceuticals: Major d) Pharmaceuticals: Generic.

$9.17  -0.07 (-0.73%)
As of 03/24/2023 16:00:00 EST     IEX book   CBOE book

ETF Information
Sponsor:     Global X Funds
Category1:  Global Equity
Category2:  Single country
Category3:  Health care
Morningstar category:  
Country:      China
Leverage factor:  1.00
Inception date:  09/24/2020
Index tracking method: Passive replication
Current yield:  0.20%
Historical average yield:  0.05%
Market cap:  $2,494,800
Average volume:  834
Fees:     0.6500%

Index Information
Solactive China Biotech Innovation Index
Index symbol:  SOLCHB
Provider:   Solactive
Index weighting:   Market capitalization
Index inception date:  12/05/2014
Backtesting data exists:   No
Number of holdings:  30
Rebalanced:  Semi-annually
Reconstituted:  Semi-annually

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy